Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

High Content Screening

By Drug Discovery Trends Editor | October 4, 2007

HCS ExplorerThermo Fisher Scientific now offers a series of software and hardware modules to enhance the functionality of its HCS/HCA platform. These include the introduction of the Thermo Scientific HCSExplorer informatics software, new functionality of its BioApplications line of image analysis software, and expanded capability of its Thermo Scientific HCS Analysis Platform.

The Thermo Scientific HCSExplorer utilizes web-based technology to enable enterprise-wide data access and analysis. This offering provides analytical, data visualization, and image comparison tools that can be used with any data storebr

BioApplications are image analysis algorithms that allow scientists to make complex measurements and are validated for a wide variety of biologies. The new Version 3 of Thermo Scientific BioApplications software has been enhanced to measure larger image sizes and more objects within any given field.

The new version 6.1 of Thermo Scientific HCS Analysis Platform provides improved image visualization due to the addition of several new image display features. The advanced Graphical User Interface reduces training time, and data from a range of third party microscopes or HCS readers can now be analyzed.
www.thermofisher.com

Published in Drug Discovery & Development magazine: Vol. 10, No. 9, September, 2007, p.26.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50